US 11236141
Targeted mutant interferon-beta and uses thereof
granted A61KA61K38/00A61K47/65
Quick answer
US patent 11236141 (Targeted mutant interferon-beta and uses thereof) held by Orionis Biosciences, Inc expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Orionis Biosciences, Inc
- Grant date
- Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K38/00, A61K47/65, A61P, A61P35/00